REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

Clinical trial NCT02580955 · UNKNOWN

Trial details

NCT number: NCT02580955
Sponsor: Flanders Medical Research Program
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2015-10-01
Primary completion: 2019-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.